JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6476
SAB Biotherapeutics
SABS
$276M
| $472 | ﹤0.01% |
104
+9
| +9% | +$50 |
2021 Q4
9 quarters
|
|
|
FABC
6477
Fabric.AI Inc
FABC
$16M
| $468 | ﹤0.01% |
18
| – | – |
2021 Q2
11 quarters
|
|
6478
a.k.a. Brands
AKA
$120M
| $467 | ﹤0.01% |
+47
| New | +$475 |
2024 Q1
0 quarters
|
|
6479
Landmark Bancorp
LARK
$191M
| $463 | ﹤0.01% |
26
| – | – |
2020 Q2
15 quarters
|
|
6480
Energous
WATT
$73.7M
| $459 | ﹤0.01% |
8
| – | – |
2021 Q1
12 quarters
|
|
6481
Barnes & Noble Education
BNED
$399M
| $458 | ﹤0.01% |
6
-4
| -40% | -$371 |
2015 Q3
34 quarters
|
|
6482
Spire Global
SPIR
$421M
| $456 | ﹤0.01% |
38
| – | – |
2021 Q3
10 quarters
|
|
|
KRON
6483
DELISTED
Kronos Bio
KRON
| $455 | ﹤0.01% |
350
| – | – |
2020 Q4
13 quarters
|
|
|
IMDX
6484
Insight Molecular Diagnostics
IMDX
$111M
| $451 | ﹤0.01% |
154
| – | – |
2017 Q4
25 quarters
|
|
|
UBX
6485
DELISTED
Unity Biotechnology
UBX
| $444 | ﹤0.01% |
271
+14
| +5% | +$24 |
2023 Q2
3 quarters
|
|
|
BQ
6486
Boqii Holding Ltd
BQ
$5.56M
| $431 | ﹤0.01% |
+177
| New | +$566 |
2024 Q1
0 quarters
|
|
6487
Provident Financial
PROV
$114M
| $428 | ﹤0.01% |
32
| – | – |
2019 Q1
20 quarters
|
|
|
HELP
6488
Helus Pharma Inc. Common Stock
HELP
$842M
| $427 | ﹤0.01% |
27
| – | – |
2023 Q3
2 quarters
|
|
6489
Akebia Therapeutics
AKBA
$244M
| $423 | ﹤0.01% |
231
| – | – |
2017 Q4
25 quarters
|
|
|
HDAW
6490
DELISTED
Xtrackers MSCI All World ex US High Dividend Yield Equity ETF
HDAW
| $423 | ﹤0.01% |
+17
| New | +$411 |
2024 Q1
0 quarters
|
|
|
LGVN
6491
Longeveron
LGVN
$8.07M
| $419 | ﹤0.01% |
13
-12
| -48% | -$805 |
2023 Q2
3 quarters
|
|
|
VTRU
6492
DELISTED
Vitru Limited Common Shares
VTRU
| $418 | ﹤0.01% |
+29
| New | +$414 |
2024 Q1
0 quarters
|
|
6493
Spyre Therapeutics
SYRE
$8B
| $417 | ﹤0.01% |
11
-30
| -73% | -$869 |
2017 Q2
27 quarters
|
|
|
CDTX
6494
DELISTED
Cidara Therapeutics
CDTX
| $415 | ﹤0.01% |
23
-49
| -68% | -$704 |
2020 Q2
15 quarters
|
|
6495
Bluerock Homes Trust
BHM
$34.3M
| $407 | ﹤0.01% |
24
+1
| +4% | +$15 |
2022 Q4
5 quarters
|
|
|
OTRK
6496
DELISTED
Ontrak
OTRK
| $407 | ﹤0.01% |
54
+51
| +1,700% | +$189 |
2019 Q1
20 quarters
|
|
6497
Spero Therapeutics
SPRO
$68.1M
| $406 | ﹤0.01% |
236
| – | – |
2017 Q4
25 quarters
|
|
6498
ProShares UltraShort Financials
SKF
$12.8M
| $402 | ﹤0.01% |
+9
| New | +$487 |
2024 Q1
0 quarters
|
|
6499
ZW Data Action Technologies
CNET
$5.8M
| $400 | ﹤0.01% |
100
| – | – |
2018 Q4
21 quarters
|
|
|
GOEV
6500
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $393 | ﹤0.01% |
6
+2
| +50% | +$139 |
2021 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.